Replies to post #3268 on Arch Therapeutics Inc (ARTH)

[Regis999]

Yes. But unlike Closure Arch has 200+- applications.

Imagine the Arch valuation if they broke up the 200 and did JV's with various Pharmas. Pressure Ulcers / Bedsores with Y. Surgery apps with X.

The longer Arch stays public the bigger the valuation.

So 500 million divided by 168 million is $ 2.98. So it is a 4.65 bagger from here.

[Regis999]

CEO 1000% This is key doc describing him. Have met once. Chairman is out of California --not critical. CEO critical and decision maker.

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=124100038

Hopelessly bias.